Already shortly after the first experimental ACT with CD8+ T cells in the mouse model of CMV infection of the immunocompromised host (22), we pursued the idea to expand low numbers of transferred cells within the mCMV-infected recipients. Here, CD8A is linked to cytomegalovirus infection.